Skip to Content

Creative Edge Nutrition Inc FITX

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

FITX is trading at a 585% premium.
Price
$0.00
Fair Value
$9.74
Uncertainty
Extreme
1-Star Price
$8.23
5-Star Price
Economic Moat
Lsws
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FITX is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
/
Market Cap
$341.10
Volume/Avg
500 / 347,227

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Creative Edge Nutrition Inc is nutritional supplement company focusing on active lifestyles. It is engaged in the development of nutraceuticals and supplements. The company offers a range of tablets, capsules, and powders as well as science based products in weight management, specific nutrition challenges, energy and fitness categories. It markets and sells its products under brand names such as Alpha drive, Aminoplex, Hemp plex, and Centro plex.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
3

Valuation

Metric
FITX
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
FITX
Quick Ratio
0.27
Current Ratio
0.27
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
FITX
Return on Assets (Normalized)
−127.76%
Return on Equity (Normalized)
−814.73%
Return on Invested Capital (Normalized)
−400.42%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRFmlqxbrxjTcyzgtp$78.2 Bil
ZTS
Zoetis Inc Class AGjrlmltwdDykh$78.0 Bil
HLN
Haleon PLC ADRPqbhqkqkDtsf$37.4 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRBnkfbsgktMth$19.1 Bil
VTRS
Viatris IncYxvntwxDmg$12.4 Bil
RDY
Dr Reddy's Laboratories Ltd ADRWtsxgpmQzk$11.8 Bil
CTLT
Catalent IncGytlyprGkcjkm$9.9 Bil
PRGO
Perrigo Co PLCDvtvcqcRrfck$3.8 Bil
CURLF
Curaleaf Holdings IncLrhdhnjcLjq$3.5 Bil
PBH
Prestige Consumer Healthcare IncPnhnhfwmPbpqx$3.2 Bil

Sponsor Center